Cargando…

An Outbreak of tet(X6)-Carrying Tigecycline-Resistant Acinetobacter baumannii Isolates with a New Capsular Type at a Hospital in Taiwan

Dissemination of multidrug-resistant, particularly tigecycline-resistant, Acinetobacter baumannii is of critical importance, as tigecycline is considered a last-line antibiotic. Acquisition of tet(X), a tigecycline-inactivating enzyme mostly found in strains of animal origin, imparts tigecycline res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Yu-Chia, Wu, Jia-Wen, Chen, Yi-Yin, Quyen, Tran Lam Tu, Liao, Wei-Chao, Li, Shiao-Wen, Chen, Yin-Cheng, Pan, Yi-Jiun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532604/ https://www.ncbi.nlm.nih.gov/pubmed/34680819 http://dx.doi.org/10.3390/antibiotics10101239

Ejemplares similares

Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
por: Hsieh, Yu-Chia, et al.
Publicado: (2020)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023)

Minocycline Susceptibility and tetB Gene in Carbapenem-Resistant Acinetobacter baumannii in Taiwan
por: Yang, Jia-Ling, et al.
Publicado: (2022)

Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients
por: Zhang, Jiangang, et al.
Publicado: (2022)

Confronting Tigecycline-Resistant Acinetobacter baumannii via Immunization Against Conserved Resistance Determinants
por: Chiang, Ming-Hsien, et al.
Publicado: (2020)

Diversity and Function of Capsular Polysaccharide in Acinetobacter baumannii
por: Singh, Jennifer K., et al.
Publicado: (2019)

Role of efflux pumps in reduced susceptibility to tigecycline in Acinetobacter baumannii
por: Ardehali, S.H., et al.
Publicado: (2019)

Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
por: Jo, Jeongwoo, et al.
Publicado: (2021)

Identification of Novel tet(X3) Variants Resistant To Tigecycline in Acinetobacter Species
por: Cheng, Yumeng, et al.
Publicado: (2022)

Genetic diversity and characteristics of high-level tigecycline resistance Tet(X) in Acinetobacter species
por: Chen, Chong, et al.
Publicado: (2020)

Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii
por: Geisinger, Edward, et al.
Publicado: (2015)

Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
por: Shin, Jung Ar, et al.
Publicado: (2012)

Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii
por: Hornsey, Michael, et al.
Publicado: (2018)

COMPARISON OF TWO DIFFERENT METHODS FOR TIGECYCLINE SUSCEPTIBILITY TESTING IN ACINETOBACTER BAUMANNII
por: Bedenić, Branka, et al.
Publicado: (2018)

Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in Acinetobacter baumannii
por: Cho, Hyejin, et al.
Publicado: (2023)

The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis
por: Liu, Cunwei, et al.
Publicado: (2023)

Alteration of adeS Contributes to Tigecycline Resistance and Collateral Sensitivity to Sulbactam in Acinetobacter baumannii
por: Yang, Yunxing, et al.
Publicado: (2023)

Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Association of capsular polysaccharide locus 2 with prognosis of Acinetobacter baumannii bacteraemia
por: Yang, Jia-Ling, et al.
Publicado: (2021)

Delirium induced by tigecycline treatment for Acinetobacter baumannii infection: A case report
por: Zheng, Xiaoying, et al.
Publicado: (2019)

Comparative Genomic Analysis of 19 Clinical Isolates of Tigecycline-Resistant Acinetobacter baumannii
por: Liu, Lin, et al.
Publicado: (2020)

Tigecycline Versus Colistin in the Treatment of Carbapenem-resistant Acinetobacter baumannii Complex Osteomyelitis
por: Oliveira, Priscila R., et al.
Publicado: (2020)

Synergistic Antibacterial Effect of Casein-AgNPs Combined with Tigecycline against Acinetobacter baumannii
por: Chen, Yu-Hsuan, et al.
Publicado: (2021)

Classification and molecular characteristics of tet(X)-carrying plasmids in Acinetobacter species
por: Chen, Chong, et al.
Publicado: (2022)

Pandrug-Resistant Acinetobacter baumannii Causing Nosocomial Infections in a University Hospital, Taiwan
por: Hsueh, Po-Ren, et al.
Publicado: (2002)

Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia
por: Deng, Yanling, et al.
Publicado: (2022)

Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
por: Zhou, Yangang, et al.
Publicado: (2019)

Spinal arachnoiditis followed by intrathecal tigecycline therapy for central nervous system infection by extremely drug-resistant Acinetobacter baumannii
por: Li, Liang-Ming, et al.
Publicado: (2020)

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
por: Principe, Luigi, et al.
Publicado: (2009)

Sensitivity of levofloxacin in combination with ampicillin-sulbactam and tigecycline against multidrug-resistant Acinetobacter baumannii
por: Madadi-Goli, Nahid, et al.
Publicado: (2017)

Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination
por: Sato, Yoshinori, et al.
Publicado: (2021)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2021)

Role of Efflux Pumps in Reduced Susceptibility to Tigecycline among Clinical Isolates of Acinetobacter baumannii
por: Mahapatra, Ashoka, et al.
Publicado: (2022)

Outcomes and prognostic factors of tigecycline treatment for hospital-acquired pneumonia involving multidrug-resistant Acinetobacter baumannii
por: Liu, Ben, et al.
Publicado: (2020)

Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in long-term care facilities in eastern Taiwan
por: Tsai, Hsin-Chi, et al.
Publicado: (2019)

A case report of intraventricular and intrathecal tigecycline infusions for an extensively drug-resistant intracranial Acinetobacter baumannii infection
por: Deng, Zi-Wei, et al.
Publicado: (2019)

Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
por: Ye, Jung-Jr, et al.
Publicado: (2016)

Tetracycline resistance mediated by tet efflux pumps in clinical isolates of Acinetobacter baumannii
por: Beheshti, Maryam, et al.
Publicado: (2020)

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
por: Niu, Tianshui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a3kaddo5s5r6ehq8f9r2r9tgo3